F8IS
AZN icon

Figure 8 Investment Strategies’s AstraZeneca AZN Stock Holding History

Figure 8 Investment Strategies’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.73M Buy
9,120
+298
+3% +$56K 1.46% 29
2026
Q1 		$1.74M Buy
8,822
+807
+10% +$156K 1.7% 25
2025
Q4 		$1.47M Sell
8,015
-10
-0.1% -$1.75K 1.31% 32
2025
Q3 		$1.23M Buy
8,025
+985
+14% +$149K 1.1% 34
2025
Q2 		$984K Buy
+7,040
New +$987K 0.96% 37

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Figure 8 Investment Strategies's AZN Position: Q2 2026 in Review

Figure 8 Investment Strategies increased its AstraZeneca (AZN) stake by 3.4% in Q2 2026, buying an estimated $56K and bringing the position to 9,120 shares worth $1.73M. The position accounts for 1.46% of the portfolio, ranked #29.

Figure 8 Investment Strategies first reported a position in AZN in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.74M in Q1 2026. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Figure 8 Investment Strategies held 9,120 shares of AstraZeneca worth $1.73M as of Q2 2026.
  • Figure 8 Investment Strategies bought 298 AstraZeneca shares in Q2 2026, an estimated $56K.
  • AstraZeneca made up 1.46% of Figure 8 Investment Strategies's portfolio in Q2 2026, its #29 holding.
  • Figure 8 Investment Strategies first reported a position in AstraZeneca in Q2 2025 and has held it in 5 quarters since.
  • Figure 8 Investment Strategies's AstraZeneca position peaked at $1.74M in Q1 2026.
  • 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Figure 8 Investment Strategies's 13F filing for Q2 2026, filed 7 Aug 2026.